<html>
<head>PUBMED IDs for hADA3</head>
<body bgcolor='#C5F0F2'><h1>hADA3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12138191/'>Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.</a> July 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12235159/'>Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator.</a> September 18  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15496419/'>Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.</a> October 22  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/18059173/'>hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin.</a> December 7  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18840648/'>Identification of ANKRD11 as a p53 coactivator.</a> October 9  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20413580/'>Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket.</a> October 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23167988/'>Identification of transcriptional and phosphatase regulators as interaction partners of human ADA3, a component of histone acetyltransferase complexes.</a> April 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/27605378/'>Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.</a> June 8  2016<br></body></html>
